UCB SA

ENXTBR:UCB Stock Report

Market Cap: €30.1b

UCB Balance Sheet Health

Financial Health criteria checks 5/6

UCB has a total shareholder equity of €10.0B and total debt of €2.8B, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are €17.3B and €7.3B respectively. UCB's EBIT is €848.0M making its interest coverage ratio 6.4. It has cash and short-term investments of €1.7B.

Key information

28.12%

Debt to equity ratio

€2.82b

Debt

Interest coverage ratio6.4x
Cash€1.67b
Equity€10.03b
Total liabilities€7.32b
Total assets€17.35b

Recent financial health updates

We Think UCB (EBR:UCB) Can Manage Its Debt With Ease

Mar 28
We Think UCB (EBR:UCB) Can Manage Its Debt With Ease

Is UCB (EBR:UCB) A Risky Investment?

Dec 24
Is UCB (EBR:UCB) A Risky Investment?

These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Sep 10
These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Recent updates

Why We Think UCB SA's (EBR:UCB) CEO Compensation Is Not Excessive At All

Apr 18
Why We Think UCB SA's (EBR:UCB) CEO Compensation Is Not Excessive At All

UCB SA's (EBR:UCB) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Apr 17
UCB SA's (EBR:UCB) Share Price Is Still Matching Investor Opinion Despite 25% Slump

We Think UCB (EBR:UCB) Can Manage Its Debt With Ease

Mar 28
We Think UCB (EBR:UCB) Can Manage Its Debt With Ease

UCB's (EBR:UCB) Earnings Are Of Questionable Quality

Mar 07
UCB's (EBR:UCB) Earnings Are Of Questionable Quality
author-image

BIMZELX's Successful Launch Will Expand Future Market Opportunities In Dermatology And Rheumatology

UCB's new product launches and high R&D success rate are driving anticipated revenue and margin growth across global markets.

UCB SA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Mar 02
UCB SA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

UCB SA (EBR:UCB) Not Lagging Market On Growth Or Pricing

Feb 28
UCB SA (EBR:UCB) Not Lagging Market On Growth Or Pricing

Is UCB (EBR:UCB) A Risky Investment?

Dec 24
Is UCB (EBR:UCB) A Risky Investment?

Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price

Oct 22
Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price

These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Sep 10
These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well

Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Jul 28
Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report

Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)

Jul 15
Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)

Financial Position Analysis

Short Term Liabilities: UCB's short term assets (€4.8B) exceed its short term liabilities (€3.5B).

Long Term Liabilities: UCB's short term assets (€4.8B) exceed its long term liabilities (€3.8B).

Debt to Equity History and Analysis

Debt Level: UCB's net debt to equity ratio (11.4%) is considered satisfactory.

Reducing Debt: UCB's debt to equity ratio has increased from 16.9% to 28.1% over the past 5 years.

Debt Coverage: UCB's debt is well covered by operating cash flow (44%).

Interest Coverage: UCB's interest payments on its debt are well covered by EBIT (6.4x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/27 12:39
End of Day Share Price 2025/05/27 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

UCB SA is covered by 51 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark van der GeestABN AMRO Bank N.V.
Kamla SinghAlphaValue
Brian BourdotBarclays